Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Invested Capital: 2017-2021

Historic Invested Capital for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to $197.2 million.

  • Cogent Biosciences' Invested Capital rose 989.50% to $197.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $197.2 million, marking a year-over-year increase of 989.50%. This contributed to the annual value of $234.7 million for FY2020, which is 638.83% up from last year.
  • Latest data reveals that Cogent Biosciences reported Invested Capital of $197.2 million as of Q3 2021, which was down 7.31% from $212.8 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Invested Capital ranged from a high of $234.7 million in Q4 2020 and a low of -$61.3 million during Q1 2018.
  • Its 3-year average for Invested Capital is $94.9 million, with a median of $39.8 million in 2019.
  • In the last 5 years, Cogent Biosciences' Invested Capital tumbled by 177.47% in 2020 and then soared by 1,005.99% in 2021.
  • Cogent Biosciences' Invested Capital (Quarterly) stood at -$48.8 million in 2017, then surged by 223.31% to $60.2 million in 2018, then crashed by 47.27% to $31.8 million in 2019, then soared by 638.83% to $234.7 million in 2020, then spiked by 989.50% to $197.2 million in 2021.
  • Its last three reported values are $197.2 million in Q3 2021, $212.8 million for Q2 2021, and $226.8 million during Q1 2021.